Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127934) titled 'Impact of Anti-Aß Antibodies on Immunometabolism in Early Alzheimer's Disease' on July 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Alzheimer's disease
Intervention:
Conventional treatment group:NA
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-07-03
Target Sample Size: Conventional treatment group:50;Anti-ß-amyloid monoclonal antibody treatment group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=2...